Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma
Clinical trial NCT05801913 · RECRUITING
Trial details
- NCT number
- NCT05801913
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-29
- Primary completion
- 2028-03-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.